The insurer's new business surged 23% year-on-year, but a one-off group contract and GST costs pushed profitability to the lower end of its guidance.
SBI Life reported a 22% rise in Q1 FY27 profit, driven by a 23% jump in new business premium. However, a large, low-margin group contract and persistent GST costs compressed value of new business margins to 26.2%.
SBI Life Insurance entered FY27 with its growth engine running hot, but a familiar tension resurfaced. The company delivered robust double-digit expansion in new business, yet a single, outsized contract and regulatory costs squeezed the profitability of that growth, landing margins at the floor of its own target range.
Revenue for the quarter ended June 2026 stood at ₹46,372 crore, up 18.9% from a year ago. Net profit grew a faster 22% to ₹725 crore. The headline growth, however, masks a sharp sequential drop in net profit margin from 13.4% to 1.6%, a function of the insurance sector's seasonality where the fourth quarter is structurally strongest.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 46,372.44YoY +19% | 5,983.71 | 38,988.77 |
| Profit (₹ Cr) | 724.93YoY +22% | 804.64 | 594.37 |
| Net Profit Margin (%) | 1.6YoY +6.7% | 13.4 | 1.5 |
The quarter's strength was broad-based. According to reports from Business Standard and The Hindu BusinessLine, new business premium jumped 23% to ₹8,910 crore. The annualised premium equivalent (APE), a key measure of new sales, surged 35.3% year-on-year to ₹5,370 crore, as noted by Prabhudas Lilladher.
But a significant portion of this surge came from a low-margin source. Management explained on the earnings call, covered by Stockwatch.live, that a large group term insurance (GTI) contract accounted for roughly a quarter of new business premium. This lumpy, lower-margin group business dragged the all-important value of new business (VNB) margin down by about 60 basis points.
The VNB margin landed at 26.2%, the lower bound of the company's 26-28% full-year guidance. The GTI deal was the primary culprit, but it wasn't alone. Reports from insights.dsij.in indicate a persistent 110-120 basis point drag from GST, which is expected to last one more quarter. Higher expenses, including stamp duty and a one-time labour-code impact, added further pressure.
Live Chart
· SBILIFE
(BSE)
ISIN: INE123W01016
This explains the 9.9% quarter-on-quarter dip in profit despite massive revenue growth. The prior quarter (Q4 FY26) benefits from peak surplus transfers from the policyholders' account, creating a high base for profitability that normalises in Q1.
Management has reaffirmed its full-year VNB margin guidance of 26-28% and indicated Q1 likely marked the bottom. As reported by CNBC-TV18, the company expects margins to move toward the upper end of that range as the lumpy group business fades and the product mix improves. The strategic shift is clear: non-ULIP products now make up 38% of the mix, with pure protection sales jumping 41%.
The company's financial backbone remains solid. The solvency ratio was a comfortable 196%, well above the regulatory minimum. While the 61-month persistency ratio dipped due to a COVID-era cohort, other metrics were stable, and normalization is expected by year-end.
Key Points
The quarter underscores SBI Life's powerful distribution engine and its ability to capture market growth, with APE soaring 35%. Yet, it also highlights the volatility that low-margin, bulk group business can inject into an otherwise steady trajectory.
The investment case now hinges on the management's assertion that this was a one-off. If the group business normalizes as expected and the GST drag lifts next quarter, the path to margin recovery is clear. Investors are left weighing robust, double-digit growth against the patience required for margins to catch up.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.